1. Home
  2. CADL vs SFHG Comparison

CADL vs SFHG Comparison

Compare CADL & SFHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$10.90

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Samfine Creation Holdings Group Limited Ordinary Share

SFHG

Samfine Creation Holdings Group Limited Ordinary Share

HOLD

Current Price

$2.21

Market Cap

9.5M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CADL
SFHG
Founded
1999
1993
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Publishing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
9.5M
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
CADL
SFHG
Price
$10.90
$2.21
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$19.00
N/A
AVG Volume (30 Days)
1.3M
22.2K
Earning Date
05-14-2026
10-30-2025
Dividend Yield
N/A
N/A
EPS Growth
58.62
N/A
EPS
N/A
N/A
Revenue
$125,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.35
$0.32
52 Week High
$14.00
$3.17

Technical Indicators

Market Signals
Indicator
CADL
SFHG
Relative Strength Index (RSI) 35.42 46.11
Support Level $9.18 $2.19
Resistance Level $10.59 $2.64
Average True Range (ATR) 0.70 0.14
MACD -0.41 -0.01
Stochastic Oscillator 11.22 46.85

Price Performance

Historical Comparison
CADL
SFHG

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About SFHG Samfine Creation Holdings Group Limited Ordinary Share

Samfine Creation Holdings Group Ltd operates through its subsidiaries. It is an established one-stop printing service provider which principally provides printing services in Hong Kong and the PRC. It offers a wide range of printed products such as book products, which mainly include children's books, educational books, art books, notebooks, diaries and journals; and novelty and packaging products, which mainly include handcraft products, book sets, pop-up books, stationery products, products with assembly parts and other specialized products, shopping bags and package boxes.

Share on Social Networks: